STAT+: Up and down the ladder: The latest comings and goings
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we\u2019ll share it with others.\u00a0That\u2019s right.\u00a0Send us your changes, and we\u2019ll find\u00a0a home for them<\/strong>. Don\u2019t be shy. Everyone wants to know who is coming and going.<\/p>\n And here is our regular feature in which we highlight a different person each week. This time around, we note that\u00a0Tevard Biosciences<\/strong> hired Elisabeth Gardiner as chief scientific officer. Previously, she worked at Tactile Therapeutics, where she was also chief scientific officer, and was an executive in residence at the venture studio General Inception, where she advised early-stage neuroscience and oncology companies.\u00a0<\/p>\n But all work and no play can make for a dull chief scientific officer.<\/strong><\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n